Drug Topics Newsletter

PHARMACISTS' REPORT

FDA Approves Triple Combination Therapy for Cystic Fibrosis

Drug able to treat 18,000 people will cost over $300k per year.

Pharmacist Collaborations Must Extend to Dentists

Common collaborations include allergy, antibiotic, and opiate consultations.

More

New Multiple Sclerosis Treatment Approved by FDA

Delayed-release oral capsules for various forms of the disease.

More

API NEXT - Generic Rx Net Pricing Built for Your Bottom Line

What’s NEXT for your pharmacy? API’s warehouse program is built to improve cash flow. With over 2,000 generic SKUs, a 20% INSTANT generic rebate, and more, API is an ideal solution for independent pharmacies.

5 New Diabetes Technologies and Treatments

Solid Tumors: What Pharmacists Need to Know

4 Facts Pharmacists Need to Know About Cancer Rates

Independent Pharmacies: Not Dead Yet